Abstract
To investigate the feasibility of applying the transcanal endoscopic approach (TEA) for surgical treatment of residual/recurrent cholesteatoma and present the preliminary results of 17 revision procedures that were carried out with this minimally invasive approach. The records of 17 patients (aged 5–76 years) who underwent transcanal revision procedure using rigid 3-mm diameter, 0°, 30° and 45° endoscopes between 2009 and 2012 were retrospectively reviewed. A wide posterior tympanomeatal flap was elevated via the external auditory canal and then transposed inferiorly in cases of cholesteatoma situated in the middle ear under a tympanic membrane. In certain cases, cholesteatoma was assessed and removed using the endoscopes directly from the radical cavity or from the mastoid cavity remaining after a canal-wall-down procedure. Six patients had originally undergone the canal-wall-up mastoidectomy, 6 patients had a canal-wall-down mastoidectomy and 5 patients had radical mastoid cavities. The interval between the previous and the index surgery ranged between 1 and 6 years. The attic was the most common site involved with cholesteatoma, followed by the tympanic portion of the facial nerve, sinus tympani, mastoid, supratubal recess, promontory, round and oval windows. The size of residual/recurrent lesion varied between 3 and 15 mm. The patients were followed up 26–67 months (mean 52.1 months). The single recurrence (a 4-mm pearl over the tympanic portion of the facial nerve) was eradicated by a transcanal re-revision 1 year following the index surgery. Minimally invasive TEA can be successfully applied in carefully selected patients with endoscopically accessible cholesteatoma subsequent to various types of mastoidectomy.
Similar content being viewed by others
References
Wilson KF, Hoggan RN, Shelton C (2013) Tympanoplasty with intact canal wall mastoidectomy for cholesteatoma: long-term surgical outcomes. Otolaryngol Head Neck Surg 149:292–295
Tomlin J, Chang D, McCutcheon B, Harris J (2013) Surgical technique and recurrence in cholesteatoma: a meta-analysis. Audiol Neurootol 18:135–142
Stew BT, Fishpool SJ, Clarke JD, Johnson PM (2013) Can early second-look tympanoplasty reduce the rate of conversion to modified radical mastoidectomy? Acta Otolaryngol 133:590–593
Stankovic M (2013) The learning curve in revision cholesteatoma surgery. Am J Otolaryngol 34:65–71
Drahy A, De Barros A, Lerosey Y, Choussy O, Dehesdin D, Marie JP (2012) Acquired cholesteatoma in children: strategies and medium-term results. Eur Ann Otorhinolaryngol Head Neck Dis 129:225–229
Gaillardin L, Lescanne E, Morinière S, Cottier JP, Robier A (2012) Residual cholesteatoma: prevalence and location. Follow-up strategy in adults. Eur Ann Otorhinolaryngol Head Neck Dis 129:136–140
Minovi A, Venjacob J, Volkenstein S, Dornhoffer J, Dazert S (2014) Functional results after cholesteatoma surgery in an adult population using the retrograde mastoidectomy technique. Eur Arch Otorhinolaryngol 271:495–501
Osborn AJ, Papsin BC, James AL (2012) Clinical indications for canal wall-down mastoidectomy in a pediatric population. Otolaryngol Head Neck Surg 147:316–322
Vercruysse JP, De Foer B, Somers T, Casselman JW, Offeciers E (2008) Mastoid and epitympanic bony obliteration in pediatric cholesteatoma. Otol Neurotol 29:953–960
Ayache S, Tramier B, Strunski V (2008) Otoendoscopy in cholesteatoma surgery of the middle ear. What benefits can be expected? Otol Neurotol 29:1085–1090
Migirov L, Shapira Y, Horowitz Z, Wolf M (2011) Exclusive endoscopic ear surgery for acquired cholesteatoma: preliminary results. Otol Neurotol 32:433–436
Badr-El-Dine M (2009) Surgery of sinus tympani cholesteatoma. Endoscopic necessity. Int Adv Otol 5:158–165
Tarabichi M (2010) Transcanal endoscopic management of cholesteatoma. Otol Neurotol 31:580–588
Marchioni D, Mattioli F, Alicandri-Ciufelli M, Presutti L (2009) Transcanal endoscopic approach to the sinus tympani: a clinical report. Otol Neurotol 30:758–765
James AL (2013) Endoscopic middle ear surgery in children. Otolaryngol Clin North Am 46:233–244
De Foer B, Vercruysse JP, Spaepen M, Somers T, Pouillon M, Offeciers E, Casselman JW (2010) Diffusion-weighted magnetic resonance imaging of the temporal bone. Neuroradiology 52:785–807
Dhepnorrarat RC, Wood B, Rajan GP (2009) Postoperative non-echo-planar diffusion-weighted magnetic resonance imaging changes after cholesteatoma surgery: implications for cholesteatoma screening. Otol Neurotol 30:54–58
Profant M, Sláviková K, Kabátová Z, Slezák P, Waczulíková I (2012) Predictive validity of MRI in detecting and following cholesteatoma. Eur Arch Otorhinolaryngol 269:757–765
Edfeldt L, Strömbäck K, Danckwardt-Lillieström N, Rask-Andersen H, Abdsaleh S, Wikström J (2013) Non-echo planar diffusion-weighted MRI increases follow-up accuracy after one-step step canal wall-down obliteration surgery for cholesteatoma. Acta Otolaryngol 133:574–583
Migirov L, Wolf M, Greenberg G, Eyal A (2014) Non-EPI DW MRI in planning the surgical approach to primary and recurrent cholesteatoma. Otol Neurotol 1:121–125
Conflict of interest
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Migirov, L., Yakirevitch, A. & Wolf, M. The utility of minimally invasive transcanal endoscopic approach for removal of residual/recurrent cholesteatoma: preliminary results. Eur Arch Otorhinolaryngol 272, 3241–3246 (2015). https://doi.org/10.1007/s00405-014-3402-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00405-014-3402-y